Trial Information

Summary: The Role of Gene Expression in Predicting Response to Chemoradiation in Advanced Rectal Cancers

You have been asked to participate in this research study because you have been diagnosed with advanced rectal cancer and have been or will be treated with preoperative chemoradiation followed by surgery.  The purpose of this study is to identify genetic markers within cancer cells that could, in the future, predict which patients can be treated effectively with preoperative chemoradiation.  Your participation will last from the time you sign the consent form until you have completed up to five years of follow-up after treatment for your rectal cancer.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: December 1, 2008 at 3:15:44 PM